Fibromyalgia
Conditions
Interventions
40 women, aged between 35 and 70 years, with confirmed diagnosis of fibromyalgia, between 1 and 3 years old, will be selected for the study by means of the presence of sensitivity in at least 11 of th
Other
Sponsors
Universidade Federal dos Vales do Jequitinhonha e Mucuri
Universidade Federal dos Vales do Jequitinhonha e Mucuri
Eligibility
Sex/Gender
Female
Age
35 Years to 70 Years
Inclusion criteria
Inclusion criteria: Women with confirmed diagnosis of fibromyalgia, according to the criteria of the American College of Rheumatology, aged between 35 and 70 years
Exclusion criteria
Exclusion criteria: voluntárias que apresentarem alguma doença concomitante que possa ser exacerbada pela atividade física; gravidez; limitações ortopédicas; doenças inflamatórias; degenerativa; articulares e respiratória ou doenças cardiovasculares; apresentar alguma doença clinicamente instável; lesão do sistema musculoesquelético; estar em acompanhamento com psiquiatra; realizar algum tipo de atividade física; hérnia aguda; trombose; diabetes; epilepsia; doenças metabólicas ou neuromusculares; lesões ortopédicas e próteses; não conseguirem suportar a intervenção; fizer uso de corticoide.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that after 6 weeks of intervention the scores of the questionnaires applied are different when compared to the scores of the first evaluation. ;Expected outcome 1: Impacto of fibromyalgia, evaluated by the Fibromyalgia Impact Questionnaire, ideal less than 70 points. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected that after 6 weeks of intervention the scores of the questionnaires applied will be different when compared to the scores of the first evaluation. Secondary outcome 1: Sleep quality, assessed by Pittsburg sleep quality index, scores near 0 points. Secondary outcome 2: Quality of life assessed by the quality of life questionnaire (SF-36): scores close to 100 points. Secondary outcome 3: Depression assessed by Beck's Depression Inventory: scores lower than 16 points. Secondary outcome 4: Pain, endorsed by visual analog pain scale: less than 5. Secondary outcome 5: Increased walking distance assessed by 6-minute walk test. Secondary Outcome 6: Increased number of reps sit and stand up from chair.;It is expected that the concentrations of the inflammatory markers evaluated (IL-6, IL-8, soluble receptors of tumor necrosis factor, sTNFR1 and sTNFR2, IL-10, neurotrophic factor derived BDNF, adipokines, adiponectin, leptin and resistin. There are no studies demonstrating normal pg / ml concentrations for this population. | — |
Countries
Brazil
Contacts
Public ContactAna Cristina Lacerda
Universidade Federal dos Vales do Jequitinhonha e Mucuri
Outcome results
None listed